Azithromycin Pediatric Dosing
Standard Oral Dosing Regimens
For most pediatric infections including community-acquired pneumonia caused by atypical pathogens, the recommended azithromycin dose is 10 mg/kg on day 1 (maximum 500 mg), followed by 5 mg/kg once daily on days 2-5 (maximum 250 mg/day). 1, 2, 3
Indication-Specific Oral Dosing
Community-Acquired Pneumonia (Atypical Pathogens):
- Day 1: 10 mg/kg as single dose
- Days 2-5: 5 mg/kg once daily
- This 5-day regimen is the most extensively studied and preferred for Mycoplasma pneumoniae and Chlamydophila pneumoniae 1, 2
Acute Otitis Media:
- Option 1 (5-day): 10 mg/kg day 1, then 5 mg/kg days 2-5 3
- Option 2 (3-day): 10 mg/kg once daily for 3 days 3
- Option 3 (single-dose): 30 mg/kg as single dose (maximum 1500 mg) 3
Acute Bacterial Sinusitis:
- 10 mg/kg once daily for 3 days 3
Pharyngitis/Tonsillitis (Streptococcal):
- 12 mg/kg once daily for 5 days (not the standard 10 mg/kg regimen) 2, 3
- The higher dose is critical—10 mg/kg for 3 days is inferior to penicillin for streptococcal pharyngitis 2
Intravenous Dosing
For hospitalized children with severe community-acquired pneumonia, the recommended IV azithromycin dose is 10 mg/kg on days 1 and 2, with transition to oral therapy as soon as clinically appropriate. 1
- Maximum single IV dose: 500 mg 4, 5
- Infuse over 1 hour (minimum 60 minutes) 4
- IV azithromycin is not FDA-approved for children <16 years but is widely used off-label based on pharmacokinetic studies 4, 5
- Pharmacokinetic data demonstrate comparable disposition in children 0.5-16 years after 10 mg/kg IV dose 5
Age-Specific Considerations
Infants 1-11 months:
- For mass distribution programs, a simplified two-tiered approach uses 80 mg (2 mL) for 1-2 months and 160 mg (4 mL) for 3-11 months, achieving 89-93% dosing accuracy 6
- Standard weight-based dosing remains preferred when feasible 6
Children ≥6 months:
- All standard regimens apply 3
Children <6 months:
- Safety and efficacy not established for most indications 3
Maximum Doses
- Single oral dose maximum: 500 mg (or 1500 mg for single-dose otitis media regimen) 3
- Daily maintenance maximum: 250 mg 3
- Single IV dose maximum: 500 mg 4
Dosing Adjustments
Renal Impairment
No dosage adjustment is required for pediatric patients with renal impairment. 3, 7
- Pharmacokinetic studies show minimal impact of renal dysfunction on azithromycin clearance 3, 7
- Only 6% of azithromycin is excreted unchanged in urine 3
- Caution advised only in severe renal impairment (GFR <10 mL/min), where AUC increases 35% 3
Hepatic Impairment
No specific dosage adjustment recommendations exist for hepatic impairment, as pharmacokinetics have not been established in this population. 3
- Emerging data suggest children with elevated ALT >40 may have 24% decreased clearance 8
- Consider 15% dose reduction in children with significant hepatic dysfunction based on pharmacokinetic modeling 8
- Exercise caution as biliary excretion is the major elimination route 3
Critical Dosing Pitfalls
Inadequate dosing promotes antimicrobial resistance and therapeutic failure. 2
- Do not use 10 mg/kg for 3 days for streptococcal pharyngitis—this is inferior to penicillin 2
- Ensure proper mg/kg calculation; body weight is the most significant predictor of clearance across all pediatric populations 9
- In children, age and liver function significantly influence clearance beyond weight alone 8, 9
Cardiac Safety Considerations:
- Azithromycin has QT-prolonging potential 10
- Avoid in patients with known QT prolongation, hypokalemia, or concurrent QT-prolonging medications 4
- Risk is particularly elevated in patients with structural heart disease 10